Incyte stock retreats as bullish momentum cools following EU approval for dermatitis drug

Traders Union
All News
Business & Wealth
Companies
Incyte drops 2.26% today

Highlights

INCY maintains a strong bullish trend across all time frames, trading well above major support clusters.
Momentum signals remain favorable, but overbought oscillators and recent profit taking indicate risk of short-term exhaustion.
Expected range for the week is $121.00 to $133.50, with an over 80% probability of a bullish breakout to new highs.

The company shared the update in a tweet and included a link for more information.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish trend structure as price holds well above key supports

INCY is trading at $126.99, well above the MA-20 ($117.01), MA-50 ($107.46), and MA-200 ($100.68), confirming strong bullish structure across short-, medium-, and long-term trends. The Ichimoku Kijun on D1 sits at $116.14, acting as immediate support below current levels; near-term support rests at the Kijun ($116.14) and MA-20 ($117.01), while key support is found at MA-50 ($107.46). Immediate resistance is seen at MA-5 ($119.79), with key resistance at the 52-week high ($132.60).

Buyer momentum challenged by overbought oscillators and recent profit taking

Momentum indicators on D1 remain constructive, with both MACD and ADX pointing to continued buyer strength. However, oscillators indicate caution: RSI is elevated at 76.76, CCI signals overbought conditions near 405, and Stoch RSI is pinned at 100, raising exhaustion risk. BBP's positive reading shows buyers dominate intraday flows, but the Awesome Oscillator remains neutral, suggesting hesitation. INCY has advanced $9.32 (7.77%) since the previous week’s close of $117.67, with price holding in the upper part of this week’s range and volatility at 15.8%. In today’s session, a pullback of 2.26% signals near-term profit taking following its recent rally.

Upside breakout favored as trend signals outweigh pullback risk

For the upcoming week, the expected trading range is $121.00 to $133.50, anchoring just below all-time highs and well above the 52-week low of $73.81. With all W1 trend indicators—RSI, ADX, MACD, and MA-50—flashing “Buy,” the probability of a breakout to the upside is very high (more than 80%), while the chance of a decline is very low. The baseline scenario is for continued sideways consolidation between $121 and $133.50. A bullish breakout above resistance could target new highs, while a bearish move below the Kijun/MA-20 support cluster may prompt a correction toward the $117–$114 zone, though such a retracement looks less likely given current strength.

In a recent review, analysts highlighted Incyte's sustained bullish momentum, supported by positive technical signals and a robust growth outlook. As current market dynamics evolve, investors should remain attentive to any shifts in momentum that could reveal new trading opportunities or potential risks.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.